Dr. Christopher William Seery, MD

Dr. Seery practices at New Vision Surgical Center - Vero Beach in Vero Beach, Florida.

Dr. Seery's NPI, 1881199768, was assigned on March 24, 2018. Dr. Seery graduated from Rutgers New Jersey Medical School in 2018. Dr. Seery holds Florida license ME155030.

Dr. Seery's primary practice is New Vision Surgical Center - Vero Beach, at 1055 37th Place, Vero Beach, FL 32960. The practice phone is (772) 257-8700.

Dr. Seery's primary practice is New Vision Surgical Center - Vero Beach in Vero Beach, Florida. Dr. Seery is also affiliated with Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Seery to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seery practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Seery's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Seery is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Seery's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Seery treats.

CMS data shows 3,466 Medicare services from Dr. Seery across 20 procedure codes in 2024, for 1,168 Medicare patients. Medicare paid $263,001 for them.

CMS counts 1,168 Medicare patients who saw Dr. Seery in 2024. The largest group is 65 to 74, with 489 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Seery's median patient age at 73, with 57% women.

In 2024, Dr. Seery wrote 1,782 Medicare Part D claims for 618 patients. 61% of them were for generic drugs. CMS names the drug for 1,634 of them, across 22 drugs with 11 or more claims each, at $1,438,802 in total drug cost. In 2023, CMS named 959 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Seery for performance year 2024, reported as part of a group. Dr. Seery accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 368 procedures of cataract surgery by Dr. Seery, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Seery, published from 2015 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Intraocular Pressure. Dr. Seery has published most often in J Pediatr Ophthalmol Strabismus. Dr. Seery's most frequent co-authors are Neelakshi Bhagat, MD, Mohammad Hossein Dastjerdi, MD and Suqin Guo, MD.

CMS Open Payments shows 27 general payments to Dr. Seery from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $358.

Dr. Seery graduated from Rutgers New Jersey Medical School in 2018.

Dr. Seery is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.